指南与共识细菌感染、耐药与抗菌药物

2025年IDSA A组链球菌咽炎指南更新:临床评分系统风险评估

2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal Pharyngitis: Risk Assessment Using Clinical Scoring Systems in Children and Adults.
指南 / 共识 · Clin Infect Dis · 2026-01-01

美国感染病学会(IDSA)发布A组链球菌(GAS)咽炎诊治指南更新第一部分,通过系统综述比较临床评分系统与单纯临床判断对咽拭子培养阳性的预测价值。证据提示评分系统诊断准确性相当或略高,但研究存在样本小、结局指标不统一等局限。专家组共识认为获益大于风险,支持使用评分系统识别低概率患者以减少不必要检测。

要点

  • 临床评分系统可辅助识别GAS咽炎低概率患者,减少不必要的快速抗原检测、分子检测或培养。
  • 评分系统诊断准确性不劣于或略优于单纯临床判断,但现有研究证据质量有限。
  • IDSA专家组共识支持将临床评分系统纳入咽痛患者评估流程。

核心结论

  • 专家组共识认为,使用临床评分系统评估咽痛患者的获益与风险平衡支持其应用。
  • 评分系统的主要效用是识别GAS咽炎低概率患者并减少不必要的检测。

研究设计与样本

  • IDSA制定的临床实践指南更新第一部分,基于对随机和非随机研究的系统综述。
  • 系统综述比较临床评分系统与单纯临床判断预测咽拭子培养结果的研究。

主要发现

  • 儿童和成人研究证据提示,临床评分系统的诊断准确性相当或略高于单纯临床判断。
  • 现有研究存在样本量小、结局指标不统一和数据不完整等局限。
  • 仅凭临床判断诊断GAS咽炎不可靠,无选择性检测给低风险个体带来费用和不便。

关键数值与推荐

  • 临床评分系统基于标准化标准量化GAS咽拭子培养阳性概率,标准包括发热、扁桃体增大或渗出物、颈前淋巴结肿大压痛及无咳嗽。
  • 评分系统用于决定患者是否需进行快速抗原检测、分子方法和/或咽拭子培养。

临床怎么用

  • 在咽痛患者评估中纳入临床评分系统,以识别GAS咽炎低概率患者。
  • 对评分提示低概率的患者减少不必要的快速抗原检测、分子检测或培养。

局限性

  • 支持评分系统诊断准确性的研究样本量小。
  • 研究间结局指标缺乏统一性且数据不完整。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

This publication represents the first part of an update to the clinical practice guideline on the diagnosis and management of group A streptococcal (Streptococcus pyogenes or GAS) pharyngitis, developed by the Infectious Diseases Society of America (IDSA). Diagnosis of GAS pharyngitis by clinician judgment alone is unreliable, and unselective testing incurs cost and inconvenience for individuals at low risk of having GAS infection. Clinical scoring systems have been used to quantify the probability of a positive GAS throat culture based on standardized criteria such as the presence of fever; tonsillar enlargement or exudate; tender and enlarged anterior cervical lymph nodes; and the absence of cough. The goal of this article is to determine whether a scoring system should be used to decide which patients should have a diagnostic test performed by rapid antigen detection test, molecular methods, and/or throat culture. We performed a systematic review of randomized and nonrandomized studies that compared the use of a clinical scoring system to clinician judgment alone in predicting the outcome of a throat culture. Evidence from studies in children and adults suggests the diagnostic accuracy of a clinical scoring system is comparable to or slightly higher than clinician judgment alone. However, the studies are limited due to small size, lack of uniformity in outcome measures, and incomplete data. The consensus of the panel is that the balance of benefits and harms favors use of a clinical scoring system as part of the evaluation of patients with sore throat. The principal utility of using a scoring system is to identify patients with low probability of GAS pharyngitis and to reduce unnecessary testing.

来源:Clin Infect Dis,查看原文。版权归原作者所有。

引用

  1. Linder JA, Watson ME, Wessels MR, et al. 2025 Clinical Practice Guideline Update by the Infectious Diseases Society of America on Group A Streptococcal Pharyngitis: Risk Assessment Using Clinical Scoring Systems in Children and Adults. Clin Infect Dis. 2026. PMID: 41343363. doi:10.1093/cid/ciaf668

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。